• 1
    Centers for Disease Control and Prevention. Folic acid and prevention of spina bifida and anencephaly. MMWR 2002; 51(RR-13): 911.
  • 2
    Bliton MJ, Zaner RM. Over the cutting edge: How ethics consultation illuminates the complexity of open-uterine fetal repair of spina bifida and patient's decision making. J Clin Ethics 2001; 12: 346360.
  • 3
    Mirzai H, Ersahin Y, Mutluer S, Kayahan A. Outcome of patients with meningomyelocele. Child's Nerv Syst 1998; 14: 120123.
  • 4
    Bruner JP, Tulipan N, Dabrowiak ME, Luker KS, Walters K, Burns P, Reed G. Upper level of the spina bifida defect: how good are we? Ultrasound Obstet Gynecol 2004; 24: 612617.
  • 5
    Bowman RM, McLone DG, Grant JA, Tomita T, Ito JA. Spina bifida outcome: A 25-year prospective. Pediatr Neurosurg 2001; 34: 114120.
  • 6
    Steinbok P, Irvine B, Cochrane DD, Irwin BJ. Long-term outcome and complications of children born with meningomyelocele. Child's Nerv Syst 1992; 8: 9296.
  • 7
    Cochrane DD, Wilson RD, Steinbok P, Farquharson DF, Irwin B, Irvine B, Chambers K. Prenatal spinal evaluation and functional outcome of patients born with myelomeningocele: Information for improved prenatal counseling and outcome prediction. Fetal Diagn Ther 1996; 11: 159168.
  • 8
    McLaurin RL. Myelomeningocele: Outcome and late complications. In Pediatric neurosurgery: Surgery of the developing nervous system, 2nd edn, Section of Pediatric Neurosurgery of the American Association of Neurological Surgeons (ed). Saunders: Philadelphia, 1989; 5370.
  • 9
    Tulipan N, Bruner JP, Hernanz-Schulman M, Lowe LH, Walsh WF, Nicklaus D, Oakes WJ. Intrauterine myelomeningocele repair: Its effect on CNS structure and function. Pediatr Neurosurg 1999; 31: 183188.
  • 10
    Rintoul N, Sutton LN, Hubbard AM, Cohen B, Melchionni A, Pasquariello PS, Adzick NS. A new look at myelomeningoceles: Functional level, vertebral level, shunting and the implications for fetal intervention. Pediatrics 2002; 109: 409413.